ArticleHemaSphere2021

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.

Erik Gaitzsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.